Compare BDTX & SPEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BDTX | SPEG |
|---|---|---|
| Founded | 2014 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.8M | 155.3M |
| IPO Year | 2020 | N/A |
| Metric | BDTX | SPEG |
|---|---|---|
| Price | $2.23 | $10.13 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $10.40 | N/A |
| AVG Volume (30 Days) | ★ 591.7K | 21.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.45 | N/A |
| EPS | ★ 0.65 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.28 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.20 | $9.95 |
| 52 Week High | $4.94 | $11.03 |
| Indicator | BDTX | SPEG |
|---|---|---|
| Relative Strength Index (RSI) | 44.24 | 60.31 |
| Support Level | $2.19 | $10.11 |
| Resistance Level | $2.67 | $10.15 |
| Average True Range (ATR) | 0.14 | 0.00 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 41.55 | 50.00 |
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
Silver Pegasus Acquisition Corp is a blank check company.